Literature DB >> 30481878

[Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis].

.   

Abstract

Current guideline developed by the Chinese Society of Hepatology on the management of hepatic encephalopathy in cirrhosis is grounded on the published evidences and panelists' consensus. This guideline presents recommendations for diagnosis and management of covert and overt hepatic encephalopathy, and underline the importance of screening minimal hepatic encephalopathy in patients with end-stage liver diseases. In addition, it also stresses that early identification and timely treatments are the means to know the prognosis. The principles of treatment are primary and secondary prevention, prompt removal of the cause, and recovery of acute neuropsychiatric abnormalities to baseline status.

Entities:  

Keywords:  Diagnosis; Hepatic encephalopathy; Liver cirrhosis; Therapy

Mesh:

Substances:

Year:  2018        PMID: 30481878     DOI: 10.3760/cma.j.issn.1007-3418.2018.10.001

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  1 in total

1.  Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome.

Authors:  Xiao Yu; Ye Jin; Wangxiao Zhou; Tingting Xiao; Zhongwen Wu; Junwei Su; Hainv Gao; Ping Shen; Beiwen Zheng; Qixia Luo; Lanjuan Li; Yonghong Xiao
Journal:  Front Cell Infect Microbiol       Date:  2022-01-18       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.